JNJ-5207787,
N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-(1-(2-cyclopentyl-ethyl)-piperidin-4yl)acrylamide,
JNJ-5207787,
683746-68-1,
JNJ 5207787,
UNII-OW44B6FA0Y,
OW44B6FA0Y,
CHEMBL21283,
(2E)-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)-4-piperidinyl]-2-propenamide,
JNJ5207787,
GTPL3504,
SCHEMBL4839763,
SCHEMBL4839776,
DTXSID60438082,
ZINC3933534,
ABP000448,
BDBM50140506,
AKOS024457931,
API0007699,
BCP9000802,
NCGC00371015-01,
2-Propenamide, N-(1-acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-(1-(2-cyclopentylethyl)-4-piperidinyl)-, (2E)-,
N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-(1-(2-cyclopentyl-ethyl)-piperidin-4yl)acrylamide,
trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-(1-(2-cyclopentylethyl)piperidin-4-yl)acrylamide,
JNJ 5207787/JNJ5207787,
(alphaE)-N-[1-(2-Cyclopentylethyl)-4-piperidinyl]-N-(1-acetyl-2,3-dihydro-1H-indole-6-yl)-3-cyanobenzeneacrylamide,
(E)-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4-yl]-acrylamide,
(E)-N-(1-acetyl-2,3-dihydroindol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]prop-2-enamide,
(E)-N-(1-acetylindolin-6-yl)-3-(3-cyanophenyl)-N-(1-(2-cyclopentylethyl)piperidin-4-yl)acrylamide,
D02WBY,
DSEJCLDJIFTPPH-FMIVXFBMSA-N,
CID10324083,
C483241,